Per- and polyfluoroalkyl substances: evaluation of liver effects using in vivo data - PFAS/2023/06
Questions on which the views of the Committee are sought
PFAS/2023/06
In this guide
In this guideThis is a paper for discussion. This does not represent the views of the Committee and should not be cited.
192. Members are invited to consider the following questions:
i). Are there any specific papers that the subgroup would like to review in more detail?
ii). Recovery is assessed in a minority of studies. Should the N/LOAEL be based on effects seen at the end of treatment or after the recovery period?
iii). Liver effects seen in developmental studies are presented for dams and offspring. The N/LOAELs are based on effects in the dam only. Does the subgroup agree with excluding effects seen in offspring, which will be reported in subsequent papers?